www.persist-ai.com

We are proud of broad network of specialists in the areas of formulation science, intellectual property rights, regulatory affairs, pharmaceutical industry veterans, and researching clinicians. Deepak is a formulation scientist trained in India and USA and is currently Assistant Professor at the Department of Pharmacy, Birla institute of Technology and Science (BITS). Deepak is focusing on advancing research programs across range of molecules / drug delivery platforms and scaling-up R&D capabilities. Mayank has 15 years of experience in multi-national consulting and pharmaceutical companies. Mayank has expertise in the areas of health economics and outcome research, medical affairs, operations, developing strategy and managing innovation. Redefine patient experience and clinical outcomes through innovative nanotechnology-based solutions. Our platform allows delivery of “difficult to deliver” active ingredients across a variety of therapeutic areas and clinical indications.

We are a team of hardcore scientists and clinicians who partner with authentic founders to create innovative and disruptive approaches that improve health and wellness. Leading the development of environmentally friendly materials in EV batteries to create a cleaner and healthier future. Developed novel chemistry that selectively delivers pharmaceuticals to a specific tissue. Neuroimaging AI software solutions that transform outcomes for research, clinical trials, and care delivery. Leading the development of benchtop automated systems for onsite lab testing. Founded by authentic entrepreneurs with deep domain expertise.

We are a close-knit team of passionate scientists, engineers and creative thinkers, all working together towards our shared goal – a future where drugs are discovered more quickly, brought to patients more cost-effectively, and through the use of less animal experimentation. We are innovators, creating cutting-edge, high-tech solutions that contribute to the development of new treatments to improve the lives of patients while reducing the need for animal testing. We are passionate about our technology and we know that CN Bio’s success depends on it being widely used. We are one team, listening and accepting, and always treating each other with respect and fairness, knowing that together we can achieve more. We are growing and evolving, constantly learning and pushing the boundaries of science and of what we can achieve. We are an organ-on-a-chip company that enables you to generate human-specific efficacy and safety data with pioneering PhysioMimix® single- and multi-organ solutions. Day to day our cohesive team design, manufacture, promote, and support organ-on-a-chip solutions that enable our customers to do something incredible – recreate three-dimensional human organs and tissues in the laboratory to better understand human physiology, disease, and the effectiveness of new drugs. Dharaminder is responsible for leading research projects within the company, often acting as the glue connecting the product development and assay development teams.

Working with pharma and biotech companies, we identified a common need for delivery solutions in drug development. Overcoming biological barriers is a crucial step to produce efficient pharmaceutical products. To improve patients’ lives by opening up new opportunities for innovative medicines.

Our vision is to connect business and science to help each unique organization perform at its best. Introducing our next-gen solution suite offering role-based graphical dashboards with Business Intelligence capabilities. From R&D tax credits to the high risk of innovation to decades long product life cycles, the life science industry is like no other. Creating new knowledge is an uncertain business, but it is the business of science. Karuna is a biopharmaceutical company driven to discover, develop and deliver transformative medicines for people living with psychiatric and neurological conditions. Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases by restoring balance to the immune system. Located in Watertown, MA, Disc Medicines is committed to building a brighter future for patients. With decades of industry experience, our platform is the only one designed specifically for the unique needs of life science companies.

We are bioengineers, drug developers and company builders.